ZA922807B - Substituted 3-(pyridinylamino)-indoles and benzo(b)thiophenes,a process for their preparation and their use as medicaments - Google Patents

Substituted 3-(pyridinylamino)-indoles and benzo(b)thiophenes,a process for their preparation and their use as medicaments

Info

Publication number
ZA922807B
ZA922807B ZA922807A ZA922807A ZA922807B ZA 922807 B ZA922807 B ZA 922807B ZA 922807 A ZA922807 A ZA 922807A ZA 922807 A ZA922807 A ZA 922807A ZA 922807 B ZA922807 B ZA 922807B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
hydrogen
chem
arylloweralkyl
pyridinylamino
Prior art date
Application number
ZA922807A
Other languages
English (en)
Inventor
Richard Charles Effland
Charles Effland Richard
Joseph Thomas Klein
Thomas Klein Joseph
Lawrence Leo Martin
Leo Martin Lawrence
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA922807B publication Critical patent/ZA922807B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA922807A 1991-04-17 1992-04-16 Substituted 3-(pyridinylamino)-indoles and benzo(b)thiophenes,a process for their preparation and their use as medicaments ZA922807B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (1)

Publication Number Publication Date
ZA922807B true ZA922807B (en) 1992-11-25

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922807A ZA922807B (en) 1991-04-17 1992-04-16 Substituted 3-(pyridinylamino)-indoles and benzo(b)thiophenes,a process for their preparation and their use as medicaments

Country Status (25)

Country Link
US (1) US5177088A (no)
EP (1) EP0509402B1 (no)
JP (1) JP2617650B2 (no)
KR (1) KR100254027B1 (no)
AT (1) ATE161840T1 (no)
AU (1) AU655253B2 (no)
BG (1) BG61034B1 (no)
CA (1) CA2066332C (no)
CS (1) CS117192A3 (no)
DE (1) DE69223837T2 (no)
DK (1) DK0509402T3 (no)
ES (1) ES2111580T3 (no)
FI (1) FI105096B (no)
GR (1) GR3026317T3 (no)
HU (1) HU215113B (no)
IE (1) IE921235A1 (no)
IL (1) IL101599A (no)
MX (1) MX9201759A (no)
NO (1) NO180486C (no)
NZ (1) NZ242359A (no)
PL (1) PL168905B1 (no)
RO (1) RO109847B1 (no)
RU (1) RU2060254C1 (no)
TW (1) TW200477B (no)
ZA (1) ZA922807B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
DK0833820T3 (da) * 1995-06-06 2001-04-17 Aventis Pharma Inc Benzisoxazol- og indazolderivater som antipsykotiske midler
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
AU720466B2 (en) * 1996-12-27 2000-06-01 Hoechst Marion Roussel, Inc. N-(pyridinylamino)isoindolines and related compounds
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
MXPA02002694A (es) * 1999-09-14 2002-07-30 Aventis Pharm Prod Inc Derivados de benzisoxazolil-, piridoisoxazolil-y benzotienil-fenoxi utiles como antagonistas de d4.
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
DE10029371A1 (de) 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
BRPI0511722A (pt) 2004-06-01 2008-01-08 Hoffmann La Roche 3-amino-1-arilpropilindóis como inibidores da recaptação de monoamina
RU2008120141A (ru) 2005-11-30 2010-01-10 Ф. Хоффманн-Ля Рош Аг (Ch) 3-амино-2-арилпропилазаиндолы и их применения
JP2009517430A (ja) * 2005-11-30 2009-04-30 エフ.ホフマン−ラ ロシュ アーゲー 3−アミノ−1−アリールプロピルインドール類及びアザ置換インドール類
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
US20100291533A1 (en) * 2008-01-04 2010-11-18 Soon Ha Kim Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166987D1 (en) * 1980-09-18 1984-12-06 Asahi Chemical Ind 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst Roussel Pharma N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
PL294239A1 (en) 1993-06-14
NO180486B (no) 1997-01-20
HU9201297D0 (en) 1992-07-28
TW200477B (no) 1993-02-21
RU2060254C1 (ru) 1996-05-20
JPH05117266A (ja) 1993-05-14
EP0509402B1 (en) 1998-01-07
IL101599A0 (en) 1992-12-30
PL168905B1 (pl) 1996-05-31
DE69223837D1 (de) 1998-02-12
AU655253B2 (en) 1994-12-08
HUT62572A (en) 1993-05-28
NZ242359A (en) 1995-03-28
GR3026317T3 (en) 1998-06-30
US5177088A (en) 1993-01-05
CS117192A3 (en) 1992-11-18
JP2617650B2 (ja) 1997-06-04
DE69223837T2 (de) 1998-06-25
EP0509402A1 (en) 1992-10-21
IL101599A (en) 1996-05-14
NO180486C (no) 1997-04-30
NO921505L (no) 1992-10-19
FI921693A (fi) 1992-10-18
ES2111580T3 (es) 1998-03-16
AU1512192A (en) 1992-10-22
MX9201759A (es) 1992-10-01
KR100254027B1 (ko) 2000-05-01
HU215113B (hu) 1998-12-28
CA2066332A1 (en) 1992-10-18
BG96202A (bg) 1993-12-24
FI921693A0 (fi) 1992-04-15
RO109847B1 (ro) 1995-06-30
BG61034B1 (bg) 1996-09-30
DK0509402T3 (da) 1998-09-07
FI105096B (fi) 2000-06-15
KR920019777A (ko) 1992-11-20
ATE161840T1 (de) 1998-01-15
NO921505D0 (no) 1992-04-15
CA2066332C (en) 2003-07-29
IE921235A1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
IL101599A0 (en) Substituted 3-(pyridinylamino)-indoles and benzo(b)thiophenes,a process for their preparation and their use as medicaments
SG48059A1 (en) 1-(Substituted pyridinylamino)-1h-indol-5-yl substituted carbamates a process and intermediate for their preparation and their use as medicaments
AU665637B2 (en) Substituted (pyridinylamino)-benzisoxazoles and -benzol{b}thiophenes, a process for their preparation and their use as medicaments
GR3025774T3 (en) Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo(b) thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments
GR3015494T3 (en) Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines, a process for their preparation and their use as modulators of neurotransmitter function.